Containment Pharma Companies Regulation 
pharmaphorum
SEPTEMBER 2, 2020
The UK’s medicines regulator has published long-awaited guidance on regulation of medicines and medical devices as the UK approaches the end of its Brexit transition period at the end of the year. Companies face significant changes in how the complex environment for medicines regulations will operate in 2021. “If
World of DTC Marketing
OCTOBER 4, 2021
SUMMARY: The Facebook whistleblower lawsuit can be summed up in one sentence: Facebook prioritizes engagement above all else because it leads to more profits even if that engagement containing inflammatory information. A year ago, Facebook was making a hard charge to get the pharma business.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Camargo
NOVEMBER 11, 2020
In October, Antares Pharma licensed Ferring Pharmaceuticals’ Nocdurna® (desmopressin acetate) sublingual tablet , which was approved in 2018 for the same indication as Noctiva and has a boxed warning highlighting the same risks. Presumably, Antares’ long-established 90-person urology sales force can achieve pull-thru of this drug product.
Pharmaceutical Technology
MAY 24, 2023
Every major pharma company is now involved in CGT development which has resulted in the approval of 28 therapies by the FDA thereby making CGT no longer a niche category of therapies. This is a primary factor for the staggeringly high unit cost of CGT. plan a, plan b, … charter flight standby option).
pharmaphorum
NOVEMBER 13, 2020
Hungary is to order a consignment of Russia’s Sputnik V COVID-19 vaccine, as the country struggles to contain the infection rate. According to press reports , the decision puts Hungary on “collision course” with the EU, which has not approved the vaccine or plans to review it either.
pharmaphorum
MARCH 26, 2021
The UK Government and EU Commission trumpeted their Brexit trade deal, struck at the end of December, as ‘comprehensive’, the ‘biggest yet’ But a closer inspection of the EU-UK Trade and Cooperation Agreement (TCA) renders these statements largely illusory for the pharma sector. The Medicinal Products Annex.
Pharma Marketing Network
FEBRUARY 5, 2025
Each country, and sometimes even individual states, has unique pricing regulations, reimbursement systems, and healthcare policies that dictate how drugs reach patients. Rising Pricing Pressures and Cost Containment Governments and insurers are tightening cost controls to manage healthcare expenditures.
Expert insights. Personalized for you.
124 
Let's personalize your content